Severe Systemic Reaction to Topical Imiquimod

被引：16

作者：

Heikkinen, Anna-Kaisa ^{[1
,2
,3
]}

Susitaival, Paivikki ^{[3
]}

机构：

[1] Oulu Univ Hosp, Dept Dermatol, FI-90029 Oulu, Finland

[2] Univ Oulu, FI-90029 Oulu, Finland

[3] N Carelia Cent Hosp, Joensuu, Finland

来源：

ACTA DERMATO-VENEREOLOGICA | 2011年 / 91卷 / 05期

关键词：

MULTIPLE ACTINIC KERATOSES; 5-PERCENT CREAM;

D O I：

10.2340/00015555-1121

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：594 / 595

页数：2

共 9 条

[1]

ABRAMOWICZ M, 2004, MED LETT DRUGS THER, V46, P92

[2] Imiquimod for actinic keratosis: Systematic review and meta-analysis [J].

Hadley, Gina ;

Derry, Sheena ;

Moore, Robert A. .

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 (06) :1251-1255

[3]

Hanger Carl, 2005, N Z Med J, V118, pU1682

[4] Pharmacokinetics and safety of imiquimod 5% cream in the treatment of actinic keratoses of the face, scalp, or hands and arms [J].

Harrison, LI ;

Skinner, SL ;

Marbury, TC ;

Owens, ML ;

Kurup, S ;

McKane, S ;

Greene, RJ .

ARCHIVES OF DERMATOLOGICAL RESEARCH, 2004, 296 (01) :6-11

[5] Pharmacokinetics of imiquimod 3.75% cream applied daily for 3 weeks to actinic keratoses on the face and/or balding scalp [J].

Kulp, James ;

Levy, Sharon ;

Fein, Melanie C. ;

Adams, Michael ;

Furst, John ;

Meng, Tze-Chiang .

ARCHIVES OF DERMATOLOGICAL RESEARCH, 2010, 302 (07) :539-544

[6] Tumor-selective induction of apoptosis and the small-molecule immune response modifier imiquimod [J].

Schön, M ;

Bong, AB ;

Drewniok, C ;

Herz, J ;

Geilen, CC ;

Reifenberger, J ;

Benninghoff, B ;

Slade, HB ;

Gollnick, H ;

Schön, MP .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (15) :1138-1149

[7] Hyperhomocysteinemia and immune activation [J].

Schroecksnadel, K ;

Frick, B ;

Winkler, C ;

Leblhuber, F ;

Wirleitner, B ;

Fuchs, D .

CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2003, 41 (11) :1438-1443

[8] Multicentre, open-label study using imiquimod 5% cream in one or two 4-week courses of treatment for multiple actinic keratoses on the head [J].

Stockfleth, E. ;

Sterry, W. ;

Carey-Yard, M. ;

Bichel, J. .

BRITISH JOURNAL OF DERMATOLOGY, 2007, 157 :41-46

[9] A randomized, double-blind, vehicle-controlled study to assess 5% imiquimod cream for the treatment of multiple actinic keratoses [J].

Stockfleth, E ;

Meyer, T ;

Benninghoff, B ;

Salasche, S ;

Papadopoulos, L ;

Ulrich, C ;

Christophers, E .

ARCHIVES OF DERMATOLOGY, 2002, 138 (11) :1498-1502

← 1 →